ATE346063T1 - Kristalline form von omeprazol - Google Patents

Kristalline form von omeprazol

Info

Publication number
ATE346063T1
ATE346063T1 AT02764081T AT02764081T ATE346063T1 AT E346063 T1 ATE346063 T1 AT E346063T1 AT 02764081 T AT02764081 T AT 02764081T AT 02764081 T AT02764081 T AT 02764081T AT E346063 T1 ATE346063 T1 AT E346063T1
Authority
AT
Austria
Prior art keywords
omeprazole
crystalline form
methoxy
disclosed
sulfiny
Prior art date
Application number
AT02764081T
Other languages
English (en)
Inventor
Milae N Hafner
Anton Eopar
Barbara Podobnik
Beleie A Cizerle
Alenka Kosak
Brina Ornik
Uros Urleb
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20432882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE346063(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Application granted granted Critical
Publication of ATE346063T1 publication Critical patent/ATE346063T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02764081T 2001-04-25 2002-04-24 Kristalline form von omeprazol ATE346063T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200100111A SI20875A (sl) 2001-04-25 2001-04-25 Kristalna oblika omeprazola

Publications (1)

Publication Number Publication Date
ATE346063T1 true ATE346063T1 (de) 2006-12-15

Family

ID=20432882

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02764081T ATE346063T1 (de) 2001-04-25 2002-04-24 Kristalline form von omeprazol

Country Status (26)

Country Link
US (2) US20040122056A1 (de)
EP (1) EP1390360B1 (de)
JP (1) JP4455815B2 (de)
KR (1) KR20030094358A (de)
CN (1) CN1531533B (de)
AT (1) ATE346063T1 (de)
AU (1) AU2002307892B2 (de)
BG (1) BG108287A (de)
BR (1) BR0209103A (de)
CA (1) CA2445251C (de)
CZ (1) CZ20032911A3 (de)
DE (1) DE60216273T2 (de)
HR (1) HRP20030853B1 (de)
HU (1) HUP0303928A2 (de)
IL (1) IL158561A0 (de)
MX (1) MXPA03009789A (de)
NO (1) NO20034715L (de)
NZ (1) NZ528917A (de)
PL (1) PL366471A1 (de)
RS (1) RS50880B (de)
RU (1) RU2286991C2 (de)
SI (2) SI20875A (de)
SK (1) SK13192003A3 (de)
UA (1) UA77671C2 (de)
WO (1) WO2002085889A1 (de)
ZA (1) ZA200307988B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
EP1904064A4 (de) * 2005-07-07 2009-12-02 Reddys Lab Ltd Dr Omeprazol form b
CN101384716B (zh) * 2006-02-22 2013-03-13 株式会社癌免疫研究所 Hla-a*3303限制性wt1肽和包含此肽的药物组合物
EP2068841B1 (de) 2006-10-05 2018-09-26 Santarus, Inc. Neuartige formulierungen von protonenpumpenhemmern und verfahren zu ihrer verwendung
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
EA200900985A1 (ru) 2007-01-31 2009-12-30 Крка, Товарна Здравил, Д. Д., Ново Место Способ получения оптически чистого омепразола
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN102786513A (zh) * 2011-05-18 2012-11-21 中国医学科学院药物研究所 奥美拉唑晶e型物质及制备方法与在药品和保健品中应用
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
KR101459088B1 (ko) * 2012-08-02 2014-12-02 대화제약 주식회사 알-라베프라졸, 이의 금속염의 제조방법
CA3235361A1 (en) * 2021-11-05 2023-05-11 Kjell JARRING Polymorphs of the hydrochloride salt of linaprazan glurate
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JP3282731B2 (ja) * 1990-06-15 2002-05-20 メルク エンド カムパニー インコーポレーテッド 結晶の構造および大きさを改良する結晶化方法
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
UA72748C2 (en) * 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
AUPQ841800A0 (en) * 2000-06-28 2000-07-20 Biomolecular Research Institute Limited Truncated egf receptor
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
MXPA03009789A (es) 2005-03-07
BR0209103A (pt) 2004-07-13
KR20030094358A (ko) 2003-12-11
RU2003133213A (ru) 2005-05-10
CN1531533A (zh) 2004-09-22
UA77671C2 (en) 2007-01-15
EP1390360B1 (de) 2006-11-22
DE60216273D1 (de) 2007-01-04
WO2002085889A1 (en) 2002-10-31
BG108287A (bg) 2005-04-30
PL366471A1 (en) 2005-02-07
JP4455815B2 (ja) 2010-04-21
US7553856B2 (en) 2009-06-30
CZ20032911A3 (en) 2004-06-16
NZ528917A (en) 2006-02-24
NO20034715D0 (no) 2003-10-21
RU2286991C2 (ru) 2006-11-10
EP1390360A1 (de) 2004-02-25
HRP20030853B1 (en) 2011-11-30
CN1531533B (zh) 2012-07-18
CA2445251A1 (en) 2002-10-31
HRP20030853A2 (en) 2005-08-31
US20040122056A1 (en) 2004-06-24
SK13192003A3 (sk) 2004-03-02
SI1390360T1 (sl) 2007-04-30
DE60216273T2 (de) 2007-05-31
HUP0303928A2 (hu) 2004-03-01
RS50880B (sr) 2010-08-31
SI20875A (sl) 2002-10-31
AU2002307892B2 (en) 2008-04-17
CA2445251C (en) 2011-01-04
IL158561A0 (en) 2004-05-12
ZA200307988B (en) 2004-10-14
US20060079560A1 (en) 2006-04-13
YU84003A (sh) 2006-08-17
JP2004526786A (ja) 2004-09-02
NO20034715L (no) 2003-12-10

Similar Documents

Publication Publication Date Title
DE60216273D1 (de) Kristalline form von omeprazol
TR200101282T2 (tr) Omeprozolün yeni kristalli formu
AR010361A1 (es) "S-OMEPRAZOL [ENANTIoMERO S DE 5-METOXI-2-[[(4--METOXI-3,5-DIMETIL-2-PIRIDINIL)-METIL]SULFINIL]-1H-BENCIMIDAZOL], EN UNA FORMA NEUTRA NO SALINA, PROCESO PARA SU PREPARACION, COMPOSICION FARMACEUTICA, Y SU USO PARA LA MANUFACTURA DE MEDICAMENTOS"
AR013350A1 (es) Sal de sodio de omeprazol forma b, proceso para su preparacion, formulacion farmaceutica, y uso de dicha sal para la fabricacion de medicamentos.
WO1998054171A8 (en) Novel form of s-omeprazole
MY119095A (en) Potassium salt of (s)-omeprazole
MY111737A (en) Use of omeprazole as an antimicrobial agent.
CL2009000805A1 (es) Composicion farmaceutica que comprende a una sal sodica del enantiomero (-) de 5-metoxi-2[[(4-metoxi-3,5-dimetil-2-piridinil)metil]sulfinil]-1h-bencimidazol ((-)-omeprazol); y su uso en la inhibicion de la secrecion de acido gastrico y para tratar enfermedades inflamatorias gastrointestinales. (divisional solicitud 3570-00).
JP2002535401A5 (de)
AR013740A1 (es) Proceso para la preparacion de omeprazol, compuesto y formulacion farmaceutica del mismo
ATE363480T1 (de) Alkylammoniumsalze von omeprazol und esomeprazol
SE0302382D0 (sv) New salts II
JP2007504223A5 (de)
JP2007504222A5 (de)
SE0302381D0 (sv) New salts I
MY118724A (en) New crystalline form of omeprazole
JP2005523298A (ja) 非心臓性胸痛の治療のためのプロトンポンプ阻害剤の使用

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1390360

Country of ref document: EP